Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Journal of Pharmacology and PharmacotherapeuticsNOW IN
    Review

    Red carpeting the newer antidiabetics

    Dilip Gude1★★ Corresponding author

    1. 1Registrar, AMC, 3rd Floor, Medwin Hospital, Chirag Ali lane, Nampally, Hyderabad, Andhra Pradesh, India Review Article.

    CORRESPONDENCE

    Dilip Gude

    Registrar, AMC, 3rd Floor, Medwin Hospital, Chirag Ali lane, Nampally, Hyderabad, Andhra Pradesh, India Review Article.

    letsgo.dilip@gmail.com

    Volume 3, Issue 2 · pp. 127–131 · PUBLISHED 2012 · DOI: 10.4103/0976-500X.95507

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    The rapidly increasing prevalence of diabetes on a global scale beseeches an urgent need for newer and better treatment options. Our better understanding of the pathophysiology of diabetes has enabled a continual churn out of newer antidiabetic agents with varying modes of action. Sodium-Glucose Transport Proteins-2 inhibitors, dipeptidyl peptidase IV inhibitors, glucagon-like peptide analogues, glucokinase activators, dual peroxisome proliferator-activated receptor agonists, monoclonal antibodies, and dopamine-2 receptor agonists either as monotherapy or combination therapy with the existing oral hypoglycemic agents compound our fight against diabetes. A review of the newer drugs targeting various aspects in the management of diabetes is presented.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Gude, D. (2012). Red carpeting the newer antidiabetics. Journal of Pharmacology and Pharmacotherapeutics, 3(2), 127–131. https://doi.org/10.4103/0976-500X.95507